Welcome to our dedicated page for Albemarle news (Ticker: ALB), a resource for investors and traders seeking the latest updates and insights on Albemarle stock.
Albemarle Corporation (NYSE: ALB) serves as a global leader in specialty chemicals and lithium production, driving innovation in energy storage and advanced manufacturing. This dedicated news hub provides investors and industry professionals with timely updates on corporate developments, financial performance, and strategic initiatives shaping the future of critical resource management.
Access authoritative reporting on ALB's integrated operations, bromine applications, and catalyst technologies. Our curated collection features official press releases, operational milestones, and market analyses—essential resources for understanding the company's role in electric vehicle supply chains and sustainable chemical solutions.
Key content categories include quarterly earnings disclosures, lithium production updates, strategic partnerships, and technological advancements. All materials maintain factual accuracy while avoiding speculative commentary, ensuring reliable information for financial decision-making.
Bookmark this page for continuous access to Albemarle's evolving business narrative. Check regularly for updates on regulatory developments, capacity expansions, and innovations in battery-grade lithium production that impact global energy transition efforts.
Albemarle Corporation (NYSE: ALB) has announced amendments to its cash tender offers, increasing the maximum principal amounts for the Dollar Tender Offer from $100 million to $128.39 million and for the Euro Tender Offer from €100 million to €122.87 million. As of the early participation date of March 12, 2021, approximately $276.78 million in Dollar Securities and €333.35 million in Euro Securities were validly tendered. The settlement date is expected on March 16, 2021, assuming all conditions are met.
Albemarle Corporation (NYSE: ALB) announced cash tender offers totaling $100 million and €100 million for its securities through its subsidiaries. The Dollar Tender Offer targets up to $100 million of senior notes, while the Euro Tender Offer aims for €100 million. The offers expire on March 26, 2021, with early participants receiving additional consideration. The settlement date for early tendered securities is expected on March 16, 2021. The offers are not subject to minimum amounts being tendered and will accept securities based on priority levels.
Albemarle Corporation (NYSE: ALB) will participate in the Goldman Sachs Chemical Intensity Days on March 9, 2021, at 9:45 a.m. ET. Eric Norris, President of Lithium, will present during the event. Interested parties can access the webcast and presentation materials through Albemarle's Events and Presentations page on their website. Albemarle, based in Charlotte, N.C., specializes in lithium, bromine, and refining catalysts, focusing on sustainable solutions across critical industries.
Albemarle Corporation (NYSE: ALB) announced two cash tender offers totaling up to $100 million in senior notes. The first, a Dollar Tender Offer, is for up to $100 million in senior notes, while the second, a Euro Tender Offer, seeks up to €100 million in notes. The offers will expire on March 26, 2021, with an early participation date of March 12, 2021. Additionally, the company plans to redeem outstanding 1.875% Senior Notes due 2021 and Floating Rate Notes due 2022. Redemption for the 2021 Notes is set for March 30, 2021, and for the Floating Rate Notes on March 16, 2021.
Albemarle Corporation (NYSE: ALB) has declared a quarterly dividend of $0.39 per share, marking an annualized rate of $1.56. This dividend is payable on April 1, 2021, to shareholders of record as of the close of business on March 12, 2021. Notably, this is the 27th consecutive year that Albemarle has increased its dividend, reflecting the company's commitment to returning value to shareholders.
Albemarle Corporation (NYSE: ALB) announced a definitive agreement to sell its Fine Chemistry Services business to W.R. Grace & Co. for approximately $570 million. The deal comprises $300 million in cash and $270 million in preferred equity from a W.R. Grace subsidiary. This strategic move aims to focus Albemarle on its core business segments. The transaction is pending regulatory approvals and is expected to close in the second quarter of 2021. BofA Securities and Troutman Pepper Hamilton Sanders LLP are advising Albemarle on this transaction.
Albemarle Corporation (NYSE: ALB) reported Q4 2020 net income of $84.6 million ($0.79 per diluted share), with adjusted diluted EPS at $1.17. Net sales reached $879 million, an 11% decline year-over-year, while adjusted EBITDA fell 25% to $221 million. Sustainable cost savings of approximately $80 million were achieved in 2020. The company maintained a quarterly dividend of $0.385, up 5% from 2019, and completed a $1.5 billion equity offering to support growth initiatives. For FY 2021, Albemarle projects net sales of $3.2 - $3.3 billion and adjusted EBITDA of $810 - $860 million.
Albemarle Corporation (NYSE: ALB) has priced a public offering of 8,496,733 shares of common stock at $153.00 per share, targeting gross proceeds of approximately $1.3 billion. The offering is set to close on February 8, 2021, pending standard conditions. Proceeds will primarily fund growth in lithium operations across Australia, Chile, and Nevada, while also addressing short-term debt and corporate needs. The underwriters have a 30-day option to purchase an additional 1,274,509 shares.
Albemarle Corporation (NYSE: ALB) announced preliminary fourth-quarter results for 2020, reporting net sales between $870 million and $880 million, a decline of 11% to 12% year-over-year. Net income is projected to range from $77 million to $87 million, down 3% to 15%. Adjusted EBITDA is estimated at $213 million to $223 million, down 24% to 28%. Despite these declines, the company expects improved performance in 2021, particularly in Lithium and Bromine sectors, driven by volume increases and ongoing cost-saving measures.
Albemarle Corporation (NYSE: ALB) has initiated an underwritten public offering of $1.3 billion in common stock, with an option for underwriters to purchase an additional $195 million. The net proceeds will primarily fund growth capital expenditures for lithium operations in Australia, Chile, and Nevada, as well as short-term debt repayment. The offering is subject to market conditions and is based on a previously filed registration statement with the SEC.
